María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
University Hospital of Zurich
Zúrich, SuizaPublikationen in Zusammenarbeit mit Forschern von University Hospital of Zurich (6)
2022
-
Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
Virchows Archiv, Vol. 481, Núm. 3, pp. 335-350
-
Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
Virchows Archiv, Vol. 481, Núm. 3, pp. 351-366
2019
-
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the committee for medicinal products for human use (chmp)
Annals of Oncology
-
Trastuzumab emtansine (T-DM1) in patients with previously treated HER2-overexpressing metastatic non–small cell lung cancer: Efficacy, safety, and biomarkers
Clinical Cancer Research, Vol. 25, Núm. 1, pp. 64-72
2011
2008
-
Can we customize chemotherapy? individualizing cytotoxic regimens in advanced non-small-cell lung cancer
Clinical Lung Cancer, Vol. 9, Núm. SUPPL. 2